About This clinical research study
MAC Clinical Research is currently conducting a trial to test a new medication for people with stable and well controlled asthma. Asthma is a common lung condition caused by inflammation of the tubes that carry air in and out of the lungs.
The purpose of this trial is to test how well the oral study medication, EDP1867, works for the symptoms of mild asthma, and other long term immunoinflammatory conditions, and to see how safe and well tolerated it is.
If the study medication is effective you may benefit from an improvement in your disease, but there is no guarantee. It is possible that you may not personally benefit from your participation in this study. However, by taking part, you will provide new information that may benefit other patients in the future.
A full description of the study will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.
Between £1200 and £1615
Clinics
Greater Manchester, Lancashire and Teesside
Therapy Area
Asthma
Gender and Age
Males and Females aged 18 - 65
A full description of the study will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full patient information sheet and an opportunity to ask the study doctor any questions.
If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.
The study will last approximately 14 weeks and consist of 12 outpatient visits at either of our Lancashire or Teesside clinics, and either, 12 outpatient visits, or one 3-night residential stay and 9 outpatient visits at our Greater Manchester clinic.
Reimbursement: Between £1200 and £1615
Key Inclusion Criteria
- Male or Female aged 18 to 65
- Mild asthma well controlled for at least 6 months
- BMI 18 – 35 kg/m2
Key Exclusion Criteria
- Other respiratory conditions e.g. Cystic Fibrosis, Pulmonary Fibrosis, or COPD
- Smokers or nicotine users within last 3 months
- Use of anti-inflammatory medications during the trial (such as ibuprofen)
Other eligibility criteria will apply. Please contact MAC for more information.
If you are eligible you will receive a comprehensive health screen. Your GP will be fully informed of your participation and provided with any information relevant to your healthcare.
ABOUT CLINICAL RESEARCH STUDIES
Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.
If the study is successful, it may be an important step towards developing a promising new treatment.
MAC Clinical Research is conducting a trial to evaluate a potential new treatment for mild asthma.
If you would like more information, please fill in the form below and we will be in touch…
Alternatively, please call our recruitment team on freephone 0800 633 5507.
Know someone who may be interested in taking part? Share this page here:
